- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Two near-identical MSD Connect emails with different subject lines were sent within seconds due to a third-party technical…
Takeda challenged AstraZeneca’s “No other LHRHa has demonstrated survival benefits in all 3 stages…” claim in a Zoladex…
PMCPA case AUTH/3075/9/18 (Director v Lundbeck) concerned clinical trial disclosure but was ruled outwith the scope of the…
A hospital pharmacist alleged ProStrakan reps discussed Abstral for post-operative urology patients (off-label). Panel found the complaint not…
A renal nurse complained that Durogesic DTrans branded pens were in BRS 2013 delegate bags. Panel found a…
MIMS “abbreviated” CosmoCol ad included pack size/cost and other claims, so needed prescribing info. Both the ad and…
Flynn sent a “Dear Doctor” letter during an Equasym supply shortage, promoting Medikinet/Medikinet XL. Panel found no issue…
A health professional alleged multiple Pfizer website items had out-of-date prescribing information. Breaches were found for Vfend and…
A GP challenged an Acomplia claim that ~50% of improvements in cardiometabolic risk factors were beyond weight loss.…
PCT prescribing advisor challenged a Bonviva leavepiece using 62% vertebral fracture reduction data from a 2.5mg daily study…
One real case. One key lesson. Every week — free.